Patents by Inventor Stanley Lorens

Stanley Lorens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycosaminoglycans for treatment of emotional dysfunctions
    Patent number: 7812005
    Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (±200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: October 12, 2010
    Inventors: Umberto Cornelli, Luigi De Ambrosi, Stanley Lorens, Jawed Fareed, John Lee, Israel Hanin, Ronald Mervis
  • Apparatus, system, method, and program for facilitating the design of electronic assemblies
    Patent number: 7458055
    Abstract: An apparatus, system, method, and program for facilitating the design of electronic assemblies include transmitting a user interface application to a user over a publicly-accessible global network. The user interface application is updated in response to electronic assembly design data entered by the user.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: November 25, 2008
    Assignee: Diversified Systems, Inc.
    Inventors: Stanley Loren Bentley, Charles Mark Henthorn, Elaine Marie Heazeltine, Tammie Lynn Bentley-Fish
  • Apparatus, system, method, and program for facilitating the design of bare circuit boards
    Patent number: 7240319
    Abstract: An apparatus, system, method, and program for facilitating the design of a bare board circuit board include transmitting a user interface application to a user over a publicly-accessible global network. The user interface application is updated in response to circuit board design data entered by the user.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: July 3, 2007
    Assignee: Diversified Systems, Inc.
    Inventors: Stanley Loren Bentley, Charles Mark Henthorn, Elaine Marie Heazeltine, Ricky Lee Thacker
  • Glycosaminoglycans for treatment of emotional dysfunctions
    Publication number: 20060205690
    Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (?200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
    Type: Application
    Filed: May 19, 2004
    Publication date: September 14, 2006
    Inventors: Umberto Cornelli, Luigi Ambrosi, Stanley Lorens, Jawed Fareed, John Lee, Israel Hanin, Ronald Mervis
  • Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia
    Patent number: 6979680
    Abstract: The present invention relates to the use of glycosaminoglycans having an average/molecular weight of 2,400 D for the preparation of pharmaceutical compositions suitable for the treatment of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: December 27, 2005
    Inventors: Umberto Cornelli, Luigi De Ambrosi, Israel Hanin, Jawed Fareed, John Lee, Stanley Lorens, Ronald F. Mervis
  • Apparatus, system, method, and program for facilitating the design of bare circuit boards
    Publication number: 20040199891
    Abstract: An apparatus, system, method, and program for facilitating the design of a bare board circuit board include transmitting a user interface application to a user over a publicly-accessible global network. The user interface application is updated in response to circuit board design data entered by the user.
    Type: Application
    Filed: February 18, 2004
    Publication date: October 7, 2004
    Inventors: Stanley Loren Bentley, Charles Mark Henthorn, Elaine Marie Heazeltine, Ricky Lee Thacker
  • Method for the enhancement of lymphocyte activity against tumors
    Patent number: 6054489
    Abstract: The invention relates to the treatment of an immunocompromised human, e.g., an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.
    Type: Grant
    Filed: November 17, 1997
    Date of Patent: April 25, 2000
    Assignee: Loyola University of Chicago
    Inventors: Stanley A. Lorens, Herbert L. Mathews, John Clancy, Jr., Joanna Goral, Brigitte Riveline
  • Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens
    Patent number: 5955508
    Abstract: The invention relates to the treatment of an immunocompromised human, e.g., an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: September 21, 1999
    Assignee: Loyola University of Chicago
    Inventors: Stanley A. Lorens, Herbert L. Mathews, John Clancy, Jr., Joanna Goral, Brigitte Riveline